Linked Life Data

18598912

Source:http://linkedlifedata.com/resource/pubmed/id/18598912

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
13-14
pubmed:dateCreated
2008-7-7
pubmed:abstractText
Most major pharmaceutical companies have employed grid computing to expand their compute resources with the intention of minimizing additional financial expenditure. Historically, one of the issues restricting widespread utilization of the grid resources in molecular modeling is the limited set of suitable applications amenable to coarse-grained parallelization. Recent advances in grid infrastructure technology coupled with advances in application research and redesign will enable fine-grained parallel problems, such as quantum mechanics and molecular dynamics, which were previously inaccessible to the grid environment. This will enable new science as well as increase resource flexibility to load balance and schedule existing workloads.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1359-6446
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
578-83
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Grid computing in large pharmaceutical molecular modeling.
pubmed:affiliation
Bristol-Myers Squibb Company, Princeton, NJ 08543-4000, USA. brian.claus@bms.com
pubmed:publicationType
Journal Article, Review